Skip to main content
SpringerLink
Log in
Book cover

Cutaneous Lupus Erythematosus pp 403–418Cite as

Immunosuppressive Drugs in Cutaneous Lupus Erythematosus

  • Chapter

  • 877 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abe Y, Seno A, Tada J, Arata J (1994) Discoid lupus erythematosus: successful treatment with oral methotrexate. Arch Dermatol 130:938–939

    Article  PubMed  Google Scholar 

  • Abud-Mendoza C, Sturbaum AK, Vazquez-Compean R, Gonzalez-Amaro R (1993) Methotrexate therapy in childhood systemic lupus erythematosus. J Rheumatol 20:731–733

    PubMed  Google Scholar 

  • Abu-Shakra M, Buskila D (2002) Update on the treatment of systemic lupus erythematosus: therapeutic highlights from the Sixth International Lupus Conference. Isr Med Assoc J 4:71–73

    PubMed  Google Scholar 

  • Abu-Shakra M. Shoenfeld Y(2001) Azathioprine therapy for patients with systemic lupus erythematosus. Lupus 10:152–153

    Article  PubMed  Google Scholar 

  • Arbisier JL, Moschella SL (1995) Clofazimine. Areview of its medical uses and mechanisms of action. J Am Acad Dermatol 32:241–247

    Article  PubMed  Google Scholar 

  • Asherson RA, Lahita RG (1991) Sex hormone modulation in systemic lupus erythematosus. Stil l a therapeutic option? Ann Rheum Dis 50:897–898

    PubMed  Google Scholar 

  • Ashinoff R, Werth VP, Frank AG Jr (1988) Resistant discoid lupus erythematosus of palms and soles: successful treatment with azathioprine. J Am Acad Dermatol 19:961–965

    PubMed  Google Scholar 

  • Ayers S Jr, Mihan R (1974) Lupus erythematosus and vitamin E:an effective and non-toxic therapy. Cutis 23:49–52

    Google Scholar 

  • Bergman J, Rico MJ (2001) Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg 20:250–259

    PubMed  Google Scholar 

  • Boehm I, Bieber T (2001) Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol 137:235–236

    PubMed  Google Scholar 

  • Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18:59–62

    Article  PubMed  Google Scholar 

  • Bohm L, Uerlich M, Bauer R (1997) Rapid improvement of subacute lupus erythematosus with low-dose methotrexate. Dermatology 194:307–308

    PubMed  Google Scholar 

  • Bottomley WW, Goodfield MJ (1995a) Methotrexate for the treatment of discoid lupus erythematosus. Br J Dermatol 133:655–656

    PubMed  Google Scholar 

  • Bottomley WW, Goodfield MJ (1995b) Methotrexate for the treatment of severe mucocutaneous lupus erythematosus. Br J Dermatol 133:311–314

    PubMed  Google Scholar 

  • Burkhardt H, Kalden JR (1997) Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases. Rheumatol Int 17:85–90

    Article  PubMed  Google Scholar 

  • Callen JP (2002) Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 16:245–264

    Article  PubMed  Google Scholar 

  • Callen JP, Spencer LV, Burruss JB, Holtman J (1991) Azathioprine: an effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127:515–522

    Article  PubMed  Google Scholar 

  • Carmichael AJ, Paul CJ (1991) Discoid lupus erythematosus responsive to sulphasalazine. Br J Dermatol 125:291–294

    Google Scholar 

  • Cohen Y, Nagler A(2002) Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support. Isr Med Assoc J 4:865–867

    PubMed  Google Scholar 

  • Conti F, Priori R, Alessandri C, Spinelli FR, Medda E, Valesini G(2000) Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A. Lupus 9:676–680

    Article  PubMed  Google Scholar 

  • Cronstein BN (1996) Molecular therapeutics. Methotrexateand its mechanism of action. Arthritis Rheum 39:1951–1960

    PubMed  Google Scholar 

  • Dalziel K, Going G, Cartwright PH, Marks R, Beveridge GW, Rowell NR (1986) Treatment of chronic discoid lupus erythematosus with an oral gold component (aurano fin). Br J Dermatol 115:211–216

    PubMed  Google Scholar 

  • De Vita S, Ferraccioli GF, Di Poi E, Bartoli E, Bombardieri S (1996) High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience. Clin Exp Rheumatol 14:S85–92

    PubMed  Google Scholar 

  • De Bandt M, Descamps V, Meyer O (2001) Etanercept-induced systemic lupus erythematosus: two cases on patients with rheumatoid arthritis. Lupus 10:S118

    Google Scholar 

  • Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre M-S, Broly F, Piette F, Bergoend H (1997) Traitementdu lupus erythemateux chronique parla sulfasalazine: 11 observations. Ann Dermatol Venereol 124:151–156

    PubMed  Google Scholar 

  • Dequet CR, Wallace DJ (2001) Novel therapies in the treatment of systemic lupus erythematosus. Curr Opin Investig Drugs 2:1045–1053

    PubMed  Google Scholar 

  • Duddridge M, Powell RJ (1997) Treatment of severeand difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis 56:690–692

    PubMed  Google Scholar 

  • Duna GF, Cash JM (1995) Treatment of refractory cutaneous lupus erythematosus. Rheum Dis Clin North Am 21:99–115

    PubMed  Google Scholar 

  • Dutz JP, Ho VC (1998) Immunosuppressive agents in dermatology. An update. Dermatol Clin 16:235–251

    Article  PubMed  Google Scholar 

  • Englert HJ, Hughes GVR (1988) Danazol and discoid lupus. Br J Dermatol 119:407–409

    PubMed  Google Scholar 

  • Ferda A (1996) Efficacy of sulfasalazinein discoid lupus erythematosus. Int J Dermatol10:746–748

    Google Scholar 

  • Furst DE (1999) Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors. Rheumatology(Oxford) 38:14–18

    Article  Google Scholar 

  • Furst DE (2002) Stem cell transplantation for autoimmune disease: progress and problems. Curr Opin Rheumatol 14:220–224

    Article  PubMed  Google Scholar 

  • Furukawa F, Imamura S, Takigawa M (1995) FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lprmice. Arch Dermatol Res 287:558–563

    Article  PubMed  Google Scholar 

  • Garcia-Porrua C, Gonzales Gay MA, Fernandez-Lamelo F, Paz-Carreira JM, Lavilla E, Gonzales-Lopez MA (1998) Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment. Clin Exp Rheumatol 16:107–108

    PubMed  Google Scholar 

  • Gasparro FP(2000) Photodermatology: progress, problems and prospects. Eur J Dermatol 10:250–254

    Google Scholar 

  • Gelfand EW (2001) Antibody-directed therapy: Past, present and future. J Allergy Clin Immunol 108:111–116

    Article  Google Scholar 

  • Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135:1124–1125

    Article  PubMed  Google Scholar 

  • Gescuk BD, Davis JC Jr (2002) Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol 14:515–521

    Article  PubMed  Google Scholar 

  • Glant TT, Mikecz K, Brennan F, Negroiu G, Bartlett R (1998) Suppression of autoimmune responses and inflammatory events by leflunomide in an animal model for rheumatoid arthritis. J Rheumatol 25:20–26

    Google Scholar 

  • Goldberg JW, Lidsky MD (1984) Pulse methylprednisolone therapyforpersist ent subacutecutaneous lupus. Art hritis Rheum 27:837–838

    Google Scholar 

  • Goldstein E, Carey W (1994) Discoid lupus erythematosus: successful treatment with oral methotrexate. Arch Dermatol 130:938–939

    Article  PubMed  Google Scholar 

  • Goyal S, Noussari HC (2001) Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol 45:142–144

    Article  PubMed  Google Scholar 

  • Graninger WB, Hassfeld W, Pesau BB, Machold KP, Zielinski CC, Smolen JS (1991) Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis. J Reumatol 18:1621–1622

    Google Scholar 

  • Gratwohl A, Passweg J, Gerber I, Tyndall A (2001) International Stem Cell Project for Autoimmune Diseases. Stem cell transplantation for autoimmune diseases. Best Pract Res Clin Haematol 14:755–776

    Article  PubMed  Google Scholar 

  • Griffiths B, Emery P (2001) The treatment of lupus with cyclosporine A. Lupus 10:165–170

    Article  PubMed  Google Scholar 

  • Hanjani NM, Noussari CH (2002) Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement. Arch Dermatol 138:1616–1618

    Article  PubMed  Google Scholar 

  • Hazelton RA, McCruden AB, Sturrock RD, Stimson WH (1983) Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis 42:155–157

    PubMed  Google Scholar 

  • Isaacs JD (2001) From bench to bedside: discovering rules for antibody design, and improving serotherapy with monclonal antibodies. Rheumatol 40:724–738

    Article  Google Scholar 

  • Isenberg D, Leckie MJ (2002) Biological treatments for systemic lupus erythematosus. Scand J Rheumatol 31:187–191

    Article  PubMed  Google Scholar 

  • Jansen GT, Dillaha CJ, Honeycutt WM (2001) Discoid lupus erythematosus. Is systemic treatment necessary? Arch Dermatol 92:283–285

    Article  Google Scholar 

  • Jayne D (1999) Non-transplant uses of mycophenolate mofetil. Curr Opin Nephrol Hypertens 8:563–567

    Article  PubMed  Google Scholar 

  • Jeffes EW 3rd, McCullough JL, Pittelkow MR, McCormick A, Almanzor J, Liu G(1995) Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth — inhibitory effects of methotrexate. J Invest Dermatol 104: 183–188

    Article  PubMed  Google Scholar 

  • Jessop S, Whitelaw D, Jordaan F (2001) Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev CD002954

    Google Scholar 

  • Jolles S, Hughes J, Whittaker S (1998) Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 134:80–86

    Article  PubMed  Google Scholar 

  • Jungers P, Kuttenn F, Liote F, Pelissier C, Athea N, Laurent MC, Viriot J, Dougados M, Bach JF (1985) Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. Arthritis Rheum 28:1243–1250

    PubMed  Google Scholar 

  • Karim MY, Alba P, Cuadrado MJ, Abbs IC, D’Cruz DP, Khamashta MA, Hughes GR (2002) Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) 41:876–882

    Article  PubMed  Google Scholar 

  • Kilian K, Banyai A, Karadi A, Miklos K, Patranyi GG, Paloczi K (1998) FK-506 (tacrolimus) therapy for an unusual SLE-like disease. Transplant Proc 30:4130–4131

    Article  PubMed  Google Scholar 

  • Knobler RM, Graninger W, Lindmaier A, Trautinger F, Smolen JS (1992) Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthrit Rheum 32:319–324

    Google Scholar 

  • Krivanek JFC, Paver WKA (1980) Further studies on the use of clofazimine in discoid lupus erythematosus. Australas J Dermatol 21:169–171

    PubMed  Google Scholar 

  • Kuhn A, Specker C, Ruzicka T, Lehmann P (2002) Methotrexatetr eatment for refractory subacutecut aneous lupus erythematosus. J Am Acad Dermatol 46:600–603

    Article  PubMed  Google Scholar 

  • Kurtz ES, Bayley SC, Arshad F, Lee AA, Przekop PA (1995) Leflunomide: an active antiin-flammatory and antiproliferative agent in models of dermatologic disease. Inflamm Res 44:187–188

    Article  PubMed  Google Scholar 

  • Lernia VD, Bisighini G (1996) Discoid lupus erythematosus during treatment with cyclosporine. Acta Derm Venereol 76:87–88

    PubMed  Google Scholar 

  • Luger T (2001) Treatment of immune-mediated skin diseases: future perspectives. Eur J Dermatol 11:343–347

    PubMed  Google Scholar 

  • Machlod KP, Smolen JS (1990) Interferon-gamma induced exacerbation of systemic lupus erythematosus. J Rheumatol 17:831–832

    PubMed  Google Scholar 

  • Martinez J, de Misa RF, Torrelo A, Ledo A (1992) Low-dose intralesional interferon alfa for discoid lupus erythematosus. J Am Acad Dermatol 26:494–496

    PubMed  Google Scholar 

  • Martinez J, de Misa RF, Boixeda P, Arrazola JM, Ledo A (1993) Long-term results of intralesional interferon alpha-2B in discoid lupus erythematosus. J Dermatol 20:444–446

    PubMed  Google Scholar 

  • Masse R, Youinou P, Dorval JC, Cledes J(1980) Reversal of lupus-erythematosus-like disease with danazol. Lancet 20:651

    Article  Google Scholar 

  • McCauliffe DP (2001) Cutaneous lupus erythematosus. Semin Cutan Med Surg 20:14–26

    PubMed  Google Scholar 

  • McGrath HJ (1994) Ultraviolet A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 12:129–135

    PubMed  Google Scholar 

  • McGrath H Jr(1997) Prospects for UV-A1 therapy as a treatment modality in cutaneous and systemic LE: Lupus 6:209–217

    Google Scholar 

  • McGrath HJ (1999) Ultraviolet A1 (340–400 nm) irradiation and systemic lupus erythematosus. J Invest Dermatol 4:79–84

    Google Scholar 

  • McGrath HJ, Bak E, Michalski JP (1987) Ultraviolet-A light prolongs survival and improves immune function (New Zealand black × New Zealand white) F1 hybrid mice. Arthritis Rheum 30:557–561

    PubMed  Google Scholar 

  • McGrath HJ, Martinez-Osuna P, Lee FA (1996) Ultraviolet A1 (340–400 nm) irradiation therapy in systemic lupus erythematosus. Lupus 5:269–274

    PubMed  Google Scholar 

  • Millard TP, Hawk JLM (2001) Ultraviolet therapy in lupus. Lupus 10:185–187

    PubMed  Google Scholar 

  • Molina N, McGrath H Jr. Longterm ultraviolet A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 24:1072–1074

    Google Scholar 

  • Moore J, Tyndall A, Brooks P (2001) Stem cells in the aetiopathogenesis and therapy of rheumatic disease. Best Pract Res Clin Rheumatol 15:711–726

    PubMed  Google Scholar 

  • Morley KD, Parke A, Hughes GRV (1982) Systemic lupus erythematosus: two patients treated with danazol. Br Med J 284:1431–1432

    Google Scholar 

  • Morris LF, Lemak NA, Arnett FC Jr, Jordon RE, Duvic M (1996) Systemic lupus erythematosus diagnosed during interferon alfa therapy. South Med J 89:810–814

    PubMed  Google Scholar 

  • Nicolas JF, Thivolet J (1989) Interferon alpha therapy in severe unresponsive subacute cutaneous lupus erythematosus. N Engl J Med 321:1550–1551

    PubMed  Google Scholar 

  • Nicolas JF, Thivolet J, Kanitakis J, Lyonnet S (1990) Response of discoid and subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 95:142S–145S

    Article  PubMed  Google Scholar 

  • Nousari HC, Kimyai-Asadi A, Tausk FA (1998) Subacute cutaneous lupus erythematosus associated with interferon beta-1a. Lancet 352:1925–1825

    Article  Google Scholar 

  • Obermoser G, Weber F, Sepp N (2001) Discoid lupus erythematosus in a patient receiving cyclosporin for liver transplantation. Acta Derm Venereol 81:319

    Article  PubMed  Google Scholar 

  • Openshaw H, Nash RA, McSweeney PA (2002) High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review. Biol Blood Marrow Transplant 8:233–248

    Article  PubMed  Google Scholar 

  • Parnham MJ (1995) Leflunomide: a potential new disease modifying anti-rheumatic drug. Exp Opin Invest Drugs 4:777–779

    Google Scholar 

  • Patel PP, Werth V(2002) Cutaneous lupus erythematosus: a review. Dermatol Clin 20:373–385

    Article  PubMed  Google Scholar 

  • Piette JC (1995) High-dose immunoglobulins in the treatment of refractory cutaneous lupus erythematosus. Open trial in 5 cases. Art hritis Rheum 38:S304

    Google Scholar 

  • Piette JC, Du LT, Papo T (1995) Postmenopausal hormone therapy and systemic lupus erythematosus. Ann Intern Med 122:961–962

    Google Scholar 

  • Pisetksky DS (2000) Tumor necrosis α blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum 43:2381–2382

    Article  PubMed  Google Scholar 

  • Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34:244–252

    PubMed  Google Scholar 

  • Reid C(2000) Drug treatmentof cutaneous lupus. Am J Clin Dermatol 1:375–379

    Google Scholar 

  • Remer CF, Weisman MH, Wallace DJ (2001) Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study. Lupus 10:480–483

    Article  PubMed  Google Scholar 

  • Richter HI, Krutmann J, Goerz G (1998) Extrakorporale Photopherese bei therapie-refraktärem disseminiertem diskoiden Lupus erythematodes. Hautarzt 49:487–491

    Article  PubMed  Google Scholar 

  • Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells and immune surveillance. N Engl J Med 341:1817–1828

    Article  PubMed  Google Scholar 

  • Rodriquez-Castellanos MA, Rubio JB, Gomez JFB, Mendoza AG (1995) Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 131:620–621

    Article  Google Scholar 

  • Ronnblom LE, Alm GV, Oberg KE (1991a) Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 115:178–183

    PubMed  Google Scholar 

  • Ronnblom LE, Alm GV, Oberg KE (1991b) Autoimmune phenomena in patients with malignant carcinoid tumors during interferon-alpha treatment. Acta Oncol 30:537–540

    PubMed  Google Scholar 

  • Rothenberg RJ, Graziano FM, Grandone JT, Goldberg JW, Bjarnason DF, Finesilver AG (1988) The use of methotrexate in steroid-resistant systemic lupus erythematosus. Arthritis Rheum 31:612–615

    PubMed  Google Scholar 

  • Rudnicka L, Szymanska E, Walecka I, Slowinska M (2000) Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. Dermatology 200:129–131

    Article  PubMed  Google Scholar 

  • Russell-Jones R(2000) Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies. Br J Dermatol 142:16–21

    Google Scholar 

  • Rutter A, Luger T(2001) High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol 44:1010–1024

    Article  PubMed  Google Scholar 

  • Sacher RA (2001) Intravenous immunoglobulin consensus statement. J Allergy Clin Immunol 108:139–146

    Article  Google Scholar 

  • Saeki Y, Oshima S, Kurimoto I, Miura H, Suemura M (2000) Maintaining remission of lupus erythematosus profundus (LEP) with cyclosprin A. Lupus 9:390–392

    Article  PubMed  Google Scholar 

  • Schanz S, Ulmer A, Rassner G, Fierlbeck G (2002) Successful treatment of subacute lupus erythematosus with mycophenolate mofetil. Br J Dermatol 147:174–178

    Article  PubMed  Google Scholar 

  • Schilling PJ, Kurzrock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536–1537

    PubMed  Google Scholar 

  • Schulz EJ, Menter MA (1971) Treatment of discoid and subacutecut aneous lupus erythematosus with cyclophosphamide. Br J Dermatol 85:60–65

    Google Scholar 

  • Singer NG, McCune WJ (1998) Update on immunosuppressive therapy. Curr Opin Rheumatol 10:169–173

    PubMed  Google Scholar 

  • Solsky M, Wallace DJ (2002) New therapies in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 16:293–312

    Article  PubMed  Google Scholar 

  • Sonnichsen N, Meffert H, Kunzelmann V, Audring H (1993) UV-A-1 therapy of subacute cutaneous lupus erythematosus. Hautarzt 44:723–725

    PubMed  Google Scholar 

  • Steinkjer B(1995) Auranofin in the treatment of discoid lupus erythematosus. J Dermatol Treat 2:27–29

    Google Scholar 

  • Sticherling M(2001) Chronic cutaneous lupus erythematosus. In: Hertl M (ed) Autoimmune disease of the skin — pathogenesis, diagnosis, management. Springer, Vienna Berlin Heidelberg New York,pp 337–364

    Google Scholar 

  • Sturgess AD, Evans DT, Mackay IR, Riglar A (1984) Effects of the oestrogen antagonist tamoxifen on disease indices in systemic lupus erythematosus. J Clin Lab Immunol 13:11–14

    PubMed  Google Scholar 

  • Tan BB, Lear TJ, Gawkrodger DJ, English JS (1997) Azathioprine in dermatology: a survey of current practice in the UK. Br J Dermatol 136:351–355

    Article  PubMed  Google Scholar 

  • Thivolet J, Nicolas JF, Kanitakis J, Lyonnet S, Chouvet B(1990) Recombinantin terferon alpha 2a is effective in the treatment of discoid and subacutecut aneous lupus erythematosus. Br J Dermatol 122:405–409

    PubMed  Google Scholar 

  • Thoma-Uszynski S, Hertl M (2001) Novel therapeutic approaches in autoimmune skin disorders. In: Hertl M (ed) Autoimmune disease of the skin — pathogenesis, diagnosis, management. Springer, Vienna Berlin Heidelberg New York, pp 337–364

    Google Scholar 

  • Torrelo A, Espana A, Medina S, Ledo A (1990) Danazol and discoid lupus erythematosus. Dermatologica 181:239

    PubMed  Google Scholar 

  • Tran QHD, Guay E, Chartier S, Tousignant J (2001) Tacrolimus in dermatology. J Cutan Med Surg 5:329–335

    PubMed  Google Scholar 

  • Traynor AE, Barr WG, Rosa RM, Rodriguez J, Oyama Y, Baker S, Brush M, Burt RK (2002) Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 46:2917–2923

    Article  PubMed  Google Scholar 

  • Tsokos GC, Caughman SW, Klippel JH (1985) Successful treatment of generalized discoid lesions with azathioprine. Its use in apatient s with systemic lupus erythematosus. Arch Dermatol 121:1323–1325

    Article  PubMed  Google Scholar 

  • Tyndall A, Koike T (2002) High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. Intern Med 41:608–612

    PubMed  Google Scholar 

  • Tyndall A, Passweg J, Grathwohl A (2000) Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases. Ann Rheum Dis 60:702–707

    Article  Google Scholar 

  • Walker SL, Kirby B, Chalmers RJ (2002) The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 147:405–406

    Article  PubMed  Google Scholar 

  • Wallace D (2001) Currentand emerging lupus treatments. Am J Manag Care 7:S490–495

    PubMed  Google Scholar 

  • Wallace DJ (2002) Management of lupus erythematosus: recent insights. Curr Opin Rheumatol 14:212–219

    Article  PubMed  Google Scholar 

  • Warner LM, Cummons T, Nolan L, Sehgal SN (1995) Sub-therapeutic doses of sirolimus and cyclosporin A in combination reduce SLE pathologies in the MRL mouse. Inflamm Res 44:S205–206

    Article  PubMed  Google Scholar 

  • Watts RA (2000) Musculoskeletal and systemic reactions to biological therapeutic agents. Curr Opin Rheumatol 12:49–54

    Article  PubMed  Google Scholar 

  • Werth V (2001) Current treatment of cutaneous lupus erythematosus. Dermatol Online J 7:2–12

    Google Scholar 

  • Werth VP (1993) Management and treatment with systemic glucocorticoids. Adv Dermatol 8:81–101

    PubMed  Google Scholar 

  • Wilder RL (1998) Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci. 840:45–50

    PubMed  Google Scholar 

  • Wilke WS, Krall PL, Scheetz RJ, Babiak T, Danao T, Mazanec DJ, Segal AM, Clough JD (1991) Methotrexate for systemic lupus erythematosus:a retrospective analysis of 17 unselected cases. Clin Exp Rheumatol 9:581–587

    PubMed  Google Scholar 

  • Wollina U, Looks A (1999) Extracorporeal photochemotherapy in cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol 13:127–130

    Article  PubMed  Google Scholar 

  • Yell JA, Burge SM (1994) Cyclosporine and discoid lupus erythematosus. Br J Dermatol 131:132–133

    PubMed  Google Scholar 

  • Yocum DE (1996) Cyclosporine, FK-506, rapamycin, and other immunomodulators. Rheum Dis Clin North Am 22:133–154

    Article  PubMed  Google Scholar 

  • Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F(2002) Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 12:50–52

    PubMed  Google Scholar 

Download references

Authors
  1. Michael Sticherling
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Annegret Kuhn  & Thomas Ruzicka  & 

  2. HELIOS Klinikum Wuppertal Klinik für Dermatologie, Allergologie und Umweltmedizin, Universitätsklinikum Witten-Herdecke, Arrenbergerstraße 20, 42117, Wuppertal, Germany

    Percy Lehmann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Sticherling, M. (2005). Immunosuppressive Drugs in Cutaneous Lupus Erythematosus. In: Kuhn, A., Lehmann, P., Ruzicka, T. (eds) Cutaneous Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26581-3_29

Download citation

  • DOI: https://doi.org/10.1007/3-540-26581-3_29

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44266-0

  • Online ISBN: 978-3-540-26581-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation